Top Markets
Coin of the day
Nanexa AB (publ) Nanexa AB (publ)

Nanexa AB (publ)

NANEXA
Rank in Stocks #22470
Nanexa AB (publ) is a firm dedicated to developing advanced drug delivery... Nanexa AB (publ) is a firm dedicated to developing advanced drug delivery solutions through nanotechnology. The company leverages its proprietary PharmaShell platform, a nanobased system that utilizes atomic layer deposition (ALD) technology for drug administration. Furthermore, Nanexa is progressing NEX-18, a PharmaShell-based candidate specifically designed to address severe conditions such as Myelodysplastic Syndrome and Acute Myeloid Leukemia. The company was established in 2007 and is headquartered in Uppsala, Sweden.
Share Price
$0.53501203
Last synced: 2026-08-21
Market Cap
$88.05M
Change (1 day)
3.01%
Change (1 year)
128.79%
Country
SE
Trade Nanexa AB (publ) (NANEXA)

Category

Operating Margin for Nanexa AB (publ) (NANEXA)
Operating Margin as of 2026 TTM: 0.00%
According to Nanexa AB (publ) latest financial reports and stock price the company's current Operating Margin (TTM) is 0.00%. At the end of 2026 the company had an Operating Margin of 0.00%.
Operating Margin history for Nanexa AB (publ) from 2026 to 2026
Operating Margin at the end of each year
Year Operating Margin Change
Not enough data for the provided dates.
Operating Margin for similar companies or competitors
Company Operating Margin Operating Margin Difference Country
0.00% -
DE
0.00% -
DE
0.00% -
JP
0.00% -
CH
22.93% -
IN
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.